Moreover, upon subcutaneous co-injection with HNSCC cells into immunocompromised mice, in vitro differentiated CD49a+ cells controlled tumor growth significantly more effectively than their CD49a− counterparts. Here, ITGA1 is linked to head and neck squamous cell carcinoma.